Cell Signaling Technology, Inc.

About Cell Signaling Technology, Inc.

Cell Signaling Technology, Inc. (CST) is a private, family owned, worldwide leader in the development and commercialization of antibodies, assays and research tools. As a company of scientists for scientists, we have developed XMT® technology, a proprietary method to develop exceptional monoclonal antibodies, PTMScan®, a technology to discover protein post-translational modifications, and PhosphoSitePlus®, an online resource for investigation of post-translational modifications. We are passionate about our role in contributing to the life science industry’s advancing of the human condition through accelerating the discovery and development of innovative therapies for human disease.  We are fully committed to developing new research tools to help define the mechanisms underlying cell function and disease, thereby broadly accelerating progress in biomedical research and medicine.


Lab Intern

June 2019 - August 2019 Danvers, MA
“One of my favourite aspects of working at CST is the people. Everyone i've worked with there has a passion for science and loves to share what they know. The internship is set up to be a learning experience, and the focus on my professional and intellectual growth helped to make this internship a wonderful experience. ”

Antibody Production Intern

May 2022 - August 2022 Beverly, MA
“I really benefitted from having an assigned mentor. I was able to quickly learn hands-on lab skills despite not having prior internship experience. I received a project for the summer that was meaningful and kept me engaged.”
See All